
Dev Institute Of Nuclear Medicine Private Limited
Provides diagnostic-imaging and healthcare services through specialty and super-specialty hospitals.
Provides diagnostic-imaging and healthcare services through specialty and super-specialty hospitals.
Dev Institute Of Nuclear Medicine Private Limited (DIONMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 April 2004 and has a history of 20 years and 11 months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.27 Cr.
The company currently has active open charges totaling ₹12.85 Cr.
Sangeeta Srivastva, Bipin Srivastava, Vihag Raman, and Two other members serve as directors at the Company.
Patna, Bihar, India
+91-XXXXXXXXXX
U85110BR2004PTC010679
010679
Private Limited Indian Non-Government Company
08 Apr 2004
31 Dec 2021
31 Mar 2021
Unlisted
Roc Patna
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vihag Raman ![]() | Director | 12-Apr-2015 | Current |
Sangeeta Srivastva ![]() | Director | 08-Apr-2004 | Current |
Bipin Srivastava ![]() | Director | 12-Apr-2015 | Current |
Ravi Kumar ![]() | Director | 15-Jan-2018 | Current |
Girish Srivastava ![]() | Director | 20-Apr-2021 | Current |
Dev Institute Of Nuclear Medicine Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 2.08% decrease. The company also saw a slight improvement in profitability, with a 1.47% increase in profit. The company's net worth Soared by an impressive increase of 24.37%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Dev Institute Of Nuclear Medicine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sangeeta Srivastva and Bipin Srivastava are mutual person
Sangeeta Srivastva and Bipin Srivastava are mutual person
Vihag Raman is a mutual person
Ravi Kumar is a mutual person
Girish Srivastava is a mutual person
₹12.85 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
26 Mar 2024 | Others | ₹4.43 M | Open |
31 Dec 2022 | Hdfc Bank Limited | ₹2.50 M | Open |
26 Jun 2019 | Others | ₹4.50 Cr | Open |
12 Feb 2016 | Hdfc Bank Limited | ₹3.24 Cr | Open |
30 Mar 2015 | India Infoline Finance Limited | ₹2.94 M | Open |
Dev Institute Of Nuclear Medicine has a workforce of 11 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dev Institute Of Nuclear Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dev Institute Of Nuclear Medicine's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 0.44 Cr with Charge ID 100897511 was registered on 26 Mar 2024.
A charge with Hdfc Bank Limited amounted to Rs. 0.25 Cr with Charge ID 100668491 was registered on 31 Dec 2022.
A charge with Hdfc Bank Limited of Rs. 3.24 Cr registered on 12 Feb 2016 with Charge ID 100021652 was modified on 18 Apr 2022.
Dev Institute Of Nuclear Medicine Private Limited last Annual general meeting of members was held on 31 Dec 2021 as per latest MCA records.
Girish Kumar Srivastava was appointed as a Director was appointed as a Director on 20 Apr 2021 & has been associated with this company since 3 years 11 months .
Dev Institute Of Nuclear Medicine Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Patna.
Dev Institute Of Nuclear Medicine Private Limited was incorporated on 08 Apr 2004.
The authorized share capital of Dev Institute Of Nuclear Medicine Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 2.27 Cr.
Currently 5 directors are associated with Dev Institute Of Nuclear Medicine Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Dev Institute Of Nuclear Medicine Private Limited is Plot No.-96B Road No.-2 Rajendra Nagar, -16. India, Patna, Bihar, 800016.
The corporate identification number (CIN) of Dev Institute Of Nuclear Medicine Private Limited is U85110BR2004PTC010679 and the company number is 010679 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2021, the revenue trend for Dev Institute Of Nuclear Medicine Private Limited has fallen by -2.08%.
As Per 2021 financial reports, 11 employees are currently employed by Dev Institute Of Nuclear Medicine Private Limited.
The financial reports for the fiscal year 2021 indicates that The net worth of Dev Institute Of Nuclear Medicine Private Limited has experienced an upsurge of 24.37%.
As per the financial statements for fiscal Year 2021, The total open charges for Dev Institute Of Nuclear Medicine Private Limited amount to ₹ 12.85 Cr.
The most recent Balance Sheet for Dev Institute Of Nuclear Medicine Private Limited was filed with the ROC on 31 Mar 2021.
DS
AK
AD